Mayo researchers see benefit in test of three-drug treatment for multiple myeloma

In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a worldwide research team led by investigators from Mayo Clinic. …read more

Source:: Cancer